A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
Objective: To study the immunogenicity and reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine (Hib-MenC-TT) when administered as a booster dose in combination with a measles, mumps and rubella vaccine (MMR). Design: A ph...
Prif Awduron: | Pace, D, Snape, M, Westcar, S, Oluwalana, C, Yu, L, Begg, N, Wysocki, J, Czajka, H, Maechler, G, Boutriau, D, Pollard, A |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
BMJ Publishing Group
2008
|
Pynciau: |
Eitemau Tebyg
-
A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.
gan: Pace, D, et al.
Cyhoeddwyd: (2008) -
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
gan: Khatami, A, et al.
Cyhoeddwyd: (2012) -
Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
gan: Snape, M, et al.
Cyhoeddwyd: (2006) -
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infants.
gan: Khatami, A, et al.
Cyhoeddwyd: (2013) -
What are the implications for childhood pneumonia of successfully introducing hib and pneumococcal vaccines in developing countries?
gan: Scott, J, et al.
Cyhoeddwyd: (2008)